Disclosure of substandard drugs to be compulsory

Published: 2007-04-10 06:58:00

Updated: 2007-04-10 06:58:00

A drug maker, importer or distributor will be required to immediately withdraw or undertake an appropriate withdrawal program against substandard drugs whenever they are found to be harmful.

The term substandard is used to describe the quality status of genuine drugs produced by legitimate man...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK